Immobilisation of an anti-platelet adhesion and anti-thrombotic drug (EP224283) on polydopamine coated vascular stent promoting anti-thrombogenic properties.

Abstract

Current vascular drug-eluting stents based on immuno-proliferative drugs would reduce the rate of in-stent restenosis (ISR) but may be associated with a higher risk of acute stent thrombosis due to non-selective activity. In this paper, we aimed to develop a polydopamine (PDA) coated chromium‑cobalt (CoCr) stent functionalised with EP224283 (Endotis Pharma SA), which combines both a GPIIbIIIa antagonist (tirofiban moiety) and a factor Xa inhibitor (idraparinux moiety) to reduce acute stent thrombosis. PDA-coated chromium‑cobalt (CoCr) samples were first immersed in a polyethylenimine (PEI, pH 8.5) solution to increase amine function density (36.0 ± 0.1 nmol/cm2) on the CoCr surface. In a second step, avidin was grafted onto CoCr-PDA-PEI through the biotin linkage (strategy 1) or directly by coupling reactions (strategy 2). The HABA titration proved the fixation of biotin onto CoCr-PDA-PEI surface with a density of 0.74 nmol/cm2. The fixation of avidin was demonstrated by water contact angle (WCA) and surface plasmon resonance (SPR). SEM micrograph shows the flexibility of the thin layer coated onto the stent after balloon inflation. Independently of the strategy, a qualitative SEM analysis showed a reduction in platelet activation when the molecule EP224283 was immobilised on avidin. In parallel, the measurement of anticoagulant activity (anti-Xa) revealed a higher anti-factor Xa activity (2.24 IU/mL vs. 0.09 IU/mL in control) when EP224283 was immobilised on avidin. Interestingly, after seven days of degradation, the anticoagulant activity was persistent in both strategies and looked more important with the strategy 2 than in strategy 1. Throughout this work, we developed an innovative vascular stent through the immobilisation of EP224283 onto CoCr-PDA-PEI-(avidin) system, which provides a promising solution to reduce ISR and thrombosis after stent implantation.

• Authors: Nicolas Bricout, Feng Chai, Jonathan Sobocinski, Adrien Hertault, William Laure, Alexandre Ung, Patrice Woisel, Joel Lyskawa, Nicolas Blanchemain
• Journal: Materials science & engineering. C, Materials for biological applications (Mater Sci Eng C Mater Biol Appl) Vol. 113 Pg. 110967 (Aug 2020) ISSN: 1873-0191 [Electronic] Netherlands
• PMID: 32487386 (Publication Type: Journal Article)
• Copyright: Copyright © 2020 Elsevier B.V. All rights reserved.

Chemical References

• Biocompatible Materials
• EP 224283
• Indoles
• Oligosaccharides
• Polymers
• polydopamine
• Chromium
• Avidin
• Cobalt
• idraparinux
• Biotin
• Polyethyleneimine
• Factor Xa

Topics

• Avidin (chemistry)
• Biocompatible Materials (chemistry, pharmacology)
• Biotin (analogs & derivatives, chemistry, pharmacology)
• Cell Survival (drug effects)
• Chromium (chemistry)
• Cobalt (chemistry)
• Drug-Eluting Stents
• Factor Xa (chemistry, metabolism)
• Human Umbilical Vein Endothelial Cells
• Humans
• Indoles (chemistry)
• Oligosaccharides (chemistry, metabolism, pharmacology)
• Platelet Activation (drug effects)
• Platelet Adhesiveness (drug effects)
• Polyethyleneimine (chemistry)
• Polymers (chemistry)
• Surface Properties